Old and New Lymphocyte Players in Inflammatory Bowel Disease

Paolo Giuffrida, Gino Roberto Corazza, Antonio Di Sabatino

Research output: Contribution to journalReview articlepeer-review


Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic intestinal inflammatory disorder characterized by diffuse accumulation of lymphocytes in the gut mucosa as a consequence of over-expression of endothelial adhesion molecules. The infiltrating lymphocytes have been identified as subsets of T cells, including T helper (Th)1 cells, Th17 cells, and regulatory T cells. The function of these lymphocyte subpopulations in the development of IBD is well-known, since they produce a number of pro-inflammatory cytokines, such as interferon-γ and interleukin-17A, which in turn activate mucosal proteases, thus leading to the development of intestinal lesions, i.e., ulcers, fistulas, abscesses, and strictures. However, the immune mechanisms underlying IBD are not yet fully understood, and knowledge about the function of newly discovered lymphocytes, including Th9 cells, innate lymphoid cells, mucosal-associated invariant T cells, and natural killer T cells, might add new pieces to the complex puzzle of IBD pathogenesis. This review summarizes the recent advances in the understanding of the role of mucosal lymphocytes in chronic intestinal inflammation and deals with the therapeutic potential of lymphocyte-targeting drugs in IBD patients.

Original languageEnglish
Pages (from-to)277-288
Number of pages12
JournalDigestive Diseases and Sciences
Issue number2
Publication statusPublished - Feb 2018


  • Animals
  • Colitis, Ulcerative/immunology
  • Crohn Disease/immunology
  • Humans
  • Intestinal Mucosa/cytology
  • Lymphocyte Subsets/physiology


Dive into the research topics of 'Old and New Lymphocyte Players in Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Cite this